Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. USO
6. AMD
7. TSLA
8. ACN
9. COHR
10. META

Go back to Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies
(NASDAQ: ERNA) Delayed: 3.96 --0 (-0%)
Previous Close $3.96    52 Week High $ 
Open $3.96    52 Week Low $ 
Day High $3.96    P/E N/A 
Day Low $3.96    EPS $ 
Volume 22